EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides

Christina Thoda, Anastasia Loukri, Antigoni Margellou, Veronica Giourieva, Konstantina Karagiota, Danai Agapi Kotopoulou, Stavroula Mystridou, Paraskevi Evangelia Panou, Theodora Papadopoulou, Ioannis Mourtzinos, Maria Touraki

Pharmaceutics · 19.11.2026 · 18 (11) · 1493

DOI: 10.3390/pharmaceutics18111493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 19.11.2026. Verfasst von Christina Thoda und 10 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Probiotic-derived peptides are promising multifunctional metabolites with significant potential for disease prevention and treatment. However, their effectiveness is hindered by their susceptibility to gastrointestinal degradation. This study aimed to develop sustainable alginate–chitosan microparticles for oral peptide delivery, using chitosan extracted from Tenebrio molitor residues.

Methods

Peptides isolated from Lactococcus lactis subsp. lactis ATCC 11454 and Bacillus subtilis subsp. subtilis NCIB 3610 were loaded into the microparticles via the external ionic gelation method. The microparticles were characterized for morphology, size, encapsulation efficiency, Fourier-Transform Infrared (FT-IR) profile, swelling, and pH-dependent release under simulated gastrointestinal conditions.

Results

Microparticles had a particle size of approximately 511–576 μm, and encapsulation efficiencies of 74.8–83.3%, comparable to commercial chitosan formulations. FT-IR analysis supported efficient peptide incorporation into the polymer matrix. The formulations exhibited pH-dependent swelling and release, with minimal release at gastric pH 1.2 and substantially greater release at intestinal pH (6.8 and 7.4). Following INFOGEST simulated gastrointestinal digestion, encapsulated peptides retained antimicrobial activity against Enterococcus faecalis and Escherichia coli, while free peptides showed significantly reduced activity (p < 0.05). Empty microparticles maintained Caco-2 cell viability above 90% across the tested concentration range, indicating cytocompatibility, whereas peptide-loaded formulations exhibited dose-dependent cytotoxicity.

Conclusions

Collectively, these findings demonstrate the potential of alginate–chitosan microparticles containing T. molitor-derived chitosan as a sustainable, pH-responsive platform for protecting antimicrobial peptides during gastrointestinal transit and facilitating intestinal delivery.

Förderung

  • Hellenic Foundation for Research and Innovation

Zitieren

APA

Thoda, C., Loukri, A., Margellou, A., Giourieva, V., Karagiota, K., Kotopoulou, D. A., Mystridou, S., Panou, P. E., Papadopoulou, T., Mourtzinos, I., & Touraki, M. (2026). pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides. Pharmaceutics, 18(11), 1493. https://doi.org/10.3390/pharmaceutics18111493

Vancouver

Thoda C, Loukri A, Margellou A, Giourieva V, Karagiota K, Kotopoulou DA, et al. pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides. Pharmaceutics. 2026;18(11):1493. doi:10.3390/pharmaceutics18111493

BibTeX
@article{Thoda2026,
  author = {Thoda, Christina and Loukri, Anastasia and Margellou, Antigoni and Giourieva, Veronica and Karagiota, Konstantina and Kotopoulou, Danai Agapi and Mystridou, Stavroula and Panou, Paraskevi Evangelia and Papadopoulou, Theodora and Mourtzinos, Ioannis and Touraki, Maria},
  title = {pH-Responsive Alginate-Chitosan Microparticles Incorporating Tenebrio molitor-Derived Chitosan for Gastrointestinal Delivery of Antimicrobial Peptides},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1493},
  doi = {10.3390/pharmaceutics18111493}
}
Kostenlos starten →